相关实验视频

Updated: Jun 9, 2025

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

通过凝介导干扰外体通信,以抵制瘤在瘤免疫微环境中的瘤适应

Kejian Shi¹, Wenjiao Fu^1,2, Zeinab Farhadi Sabet¹

¹CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, New Cornerstone Science Laboratory, National Center for Nanoscience and Technology of China, Beijing 100190, People's Republic of China.

|October 23, 2024

概括

这项研究介绍了PepABS-py,这是一种新型的酸水凝,可以阻断瘤外生体释放,并对抗低氧瘤微环境. 这种方法增强了CD8+ T细胞的透,并支持传统化疗.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症生物学癌症生物学

背景情况:

固体瘤通常具有缺氧特征,促进瘤外生体,有助于免疫逃避和适应能力.
化疗可以触发瘤迁移和免疫抑制,使治疗复杂化.
当前的纳米技术提供了针对瘤微环境的策略.

研究的目的:

开发一种膜向的治疗策略,以阻止外体细胞扩散并减轻缺氧瘤微环境.
为了研究一个自我组装的短 (PepABS-py) 水凝在癌症治疗中的有效性.
评估PepABS-py对免疫细胞透和瘤适应的影响.

主要方法:

在瘤细胞表面应用自组装的PepABS-py酸水凝.
使用PepABS-py通过类似纤维的纳米结构阻止外体散布.
将CA IX酶抑制剂纳入PepABS-py中,以减轻缺氧瘤微环境.
分析外体载体中微RNAs的调节及其对T细胞信号通路的影响.

主要成果:

PepABS-py水凝有效地阻断了外体散布,并限制了系统性副作用.
在体内给药PepABS-py减弱了缺氧瘤微环境.
PepABS-py调节的外体微RNA载荷,增强CD8+ T细胞透.
在转移部位的炎症单细胞得到缓解.

结论:

PepABS-py作为一个有前途的瘤膜向治疗工具.
这种化水凝有效地抵制了免疫微环境中的瘤适应.
通过抑制外体细胞沟通和增强抗瘤免疫力,PepABS-py可以推进传统化疗.

关键词:

外基因组的沟通方式这是一种水凝.缺氧缺氧是指缺氧的情况.瘤适应瘤适应瘤免疫的微环境

更多相关视频

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.